A randomized controlled trial of oral sucrose solution for prevention of hypoglycemia in high risk infants

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190731002

Enrollment

203

Registered

2019-07-31

Start date

2019-07-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small for gestational age infants Large for gestational age infants Infants of diabetic mother SGA LGA IDM

Interventions

24% oral sucrose suspension,No treatment

Experimental Other,No Intervention No treatment

24%oral sucrose and formula feeding,formula feeding

Eligibility

Sex/Gender

All

Age

1 Days to 7 Days

Inclusion criteria

Inclusion criteria: Infants born in Phramongkutklao hospital Infants with gestational age from 35 weeks of gestation -small for gestational age -large for gestational age -infant of diabetic mother Parental permission

Exclusion criteria

Exclusion criteria: infants with symptomatic hypoglycemia congenital anomalies, dysmorphic feature congenital infection feeding intolerance

Design outcomes

Primary

Measure	Time frame
blood glucose immediate, 30 minutes,1 hour after birth heel-stick method	—

Secondary

Measure	Time frame
incidence of complication of hypoglycemia within 7 days of life monitoring clinical manifestation	—

Countries

Thailand

Contacts

Public ContactNithipun Suksumek

PMK

drnithipun@hotmail.com0863060003

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026